期刊文献+

喉癌中抗凋亡基因bcl-2蛋白的表达及其临床意义 被引量:2

Title:EXPRESSIONOFANTI- APOPTICPROTEINbcl-2 INLARYNGEALCARCINOMA ANDITSCLINICALSIGNIFICANCE
下载PDF
导出
摘要 目的 探讨细胞凋亡抑制基因bcl- 2 蛋白产物在喉癌中的表达及其临床意义。方法 应用免疫组化SABC方法检测41 例喉癌切除标本石蜡切片组织。结果 bcl- 2 蛋白在喉癌组织中有过度表达,其阳性表达率为512 % (24/41) ;bcl- 2 表达与喉癌病理组织学分级相关,肿瘤分化程度越高,bcl- 2 阳性表过率越高( P< 005) ,早期( Ⅰ、Ⅱ期) 喉癌中bcl- 2 表达明显高于晚期( Ⅲ、Ⅳ期)( P<005) ;bcl- 2 表达与肿瘤复发、转移无关P> 005) ;而与预后明显相关,bcl- 2 阳性组三年生存率明显高于阴性组P< 005) 。结论 bcl- 2 基因在喉癌中有异常表达,与喉癌的发生、发展相关。 Objective:In orderto study the expression of anti- apoptic gene bcl- 2 inlaryngealcarcinoma and its clinicalsignificance,41 cases oflaryngeal carcinoma were observed byimmunohistochemical SABCmethod . Methods:ImmunohistochemicalSABCwas used.Results: Overexpression of bcl- 2 protein could be deteded in la ryngealcarcinoma and its positive rate was 51 .2 % (21/41) . The expression of bcl- 2 protein was related with the degree of pathological differentiation oflaryngeal carcinoma:the hitherthe differentiation ,the higherthe expression ( P< 0 05) .Andthe expression of bcl- 2 in early stage ( Ⅰ,Ⅱ) was higherthan thatoflate stage ( Ⅲ,Ⅳ) ,but there was no difference betweenthe expressionin lymphatic metastatic group,recurrentgroup and non - metastatic or non- recurrent group(( P> 0 05) . Conclusion :bcl- 2 gene is abnomaly expressed in laryngeal carcinoma which suggestedit may plays animportantroleintherumorigenesis and developmentoflaryngealcarcinoma ,and bcl- 2 ex pression could be used as a good markerrelatingtothe prognosis oflaryngealcarcinoma .
出处 《泰山医学院学报》 CAS 1999年第3期262-263,共2页 Journal of Taishan Medical College
关键词 喉肿癌 免疫组织化学 BCL-2 laryngeal carcinoma immunohistochemistry bcl- 2
  • 相关文献

同被引文献24

  • 1古保亮,邹伟,张岩峰,杨梅怀,官磊.bcl-2蛋白在肺癌中表达及其与预后关系[J].齐鲁医学杂志,1998,13(3):161-162. 被引量:2
  • 2曾桂生,陈亚兵,温龙平,俞春东,蔡毓.bax基因促进细胞编程死亡的机理研究[J].生命科学,1996,8(1):46-47. 被引量:7
  • 3赵永同,朱峰.凋亡的分子机理[J].生命科学,1996,8(2):19-23. 被引量:24
  • 4Kim N. Chi,Anne E. Wallis,Chow Hwee Lee,Daniel Lopez de Menezes,Jason Sartor,Wieslawa H. Dragowska,Lawrence D. Mayer. Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression[J] 2000,Breast Cancer Research and Treatment(3):199~212
  • 5George K. Charalambous,Ilias P. Gomatos,Manoussos M. Konstadoulakis,Evangelos G. Messaris,Andreas J. Manouras,Anastasia E. Apostolou,Emmanuel A. Leandros,Maria K. Karayannis,George A. Androulakis. Protein Expression of bax, bcl-2, and p53 in Patients with Non-Hodgkin’s Gastric Lymphoma: Prognostic Significance[J] 2000,World Journal of Surgery(5):608~614
  • 6Polyak K,Lee MH,Enrdjumentl BH, et al., a cyclin-dependent kinase inhibitor and a potenial mediator of extrcelluar antimitogenic signals[].Cell.1994
  • 7Coat S,Flanagan WM,Nourse J, et al.for restriction point control of the fibrobast cell cycle[].Science.1996
  • 8Salvesen Gs,Dixit VM.Caspaae activation: The induced-promity model[].Proceedings of the National Academy of Sciences of the United States of America.1999
  • 9Katayose Y,Kim M,Rakkar A N S,et al.Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27[].Cancer Research.1997
  • 10Tao X J,Tilly K I,Maravei D V,et al.Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax[].The Journal of Clinical Endocrinology.1997

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部